Skip to main content

Publications

Publications

A Comparative Analysis of Reimbursement Outcomes for Orphan Drugs Between EU and Non-EU Countries

Sarah Jane Lyttle, Harry Lewis, Andrew Mumford

Published on 28 November 2024
The importance of rare disease-specific procedures in HTA processes in ensuring equitable access to orphan products as a result of EU JCA

Adelaide Shaw-Maguire, Cameron Huke, Georgia Roberts, James Wantling, Andrew Mumford

Published on 2 December 2024
A review and evaluation of successfully reimbursed orphan and non-orphan drugs in Ireland

Myrtle Greenwood, Sarah Jane Lyttle, Andrew Mumford, Georgia Roberts

Published on 1 June 2023
The economic impact and variability of managing distal renal tubular acidosis (dRTA) in the UK healthcare setting

Scott Donald, Catherine Matre, Andrew Mumford, Joanne Mumford

Published on 1 November 2019
PICO consolidation in European HTA scoping: Examining PICO variations in oncology drugs in the context of the European Joint Clinical Assessment

Oliver Darlington, Jonathan Gibson, Daniel Hollard, Georgia Roberts, Imogen Taylor

Published on 1 June 2024
Cost-effectiveness analysis of paclitaxel micellar for treatment of first relapse platinum sensitive ovarian cancer

Tom Edmonds, Bethany English, Clive Witcher, Andrew Mumford

Published on 1 December 2022

Listen to our podcast: Initiation

Working with Initiate | What to expect working with our market access and health economics consultancy | Initiation Podcast

Developing PROMs in rare diseases | A conversation with Benson Chen from MitoCAMB | Initiation Podcast

Insights from the 2023 Reimbursement Radar wrap-up | Initiation Podcast

View more in Spotify

© Copyright 2025 Initiate Consultancy is a limited company.
Registered in England and Wales. Reg No. 11903774 | Privacy Policy

Let’s discuss your purpose

hello@initiateconsultancy.com
0203 759 0505